intellectual_property

Tokyo -- Kaneka Corporation will appeal a September 2, 2026 ruling by the U.S. District Court for the Eastern District of New York that invalidated its U.S. Patent No. 7,829,080 covering reduced coenzyme Q10, known as ubiquinol.

New York court dismisses infringement case on enablement grounds

The court dismissed Kaneka's litigation against Cocrystal Technology (Jiaxing) Co., Ltd. and Cocrystal Health Industry (Zhejiang) Co., Ltd., ruling the '080 Patent invalid for lack of enablement. The case, filed October 5, 2023 under case number 1:23-cv-7483-SJB-SDE, had alleged that CoCrystal's ubiquinol supplements infringed claims 5 and 15 of the patent.

Grand Rapids, Mich. – – September 12, 2026 -- Shoulder Innovations, Inc. (NYSE: SI) has settled all outstanding patent litigation with Catalyst OrthoScience Inc., ending a legal dispute between the two shoulder-implant makers under confidential terms.

Shoulder Innovations resolves patent dispute with Catalyst OrthoScience under sealed terms

The settlement agreement closes all pending patent claims between Shoulder Innovations and Catalyst OrthoScience without disclosing financial or licensing terms.

CEO Rob Ball says the deal protects intellectual property tied to shoulder arthroplasty innovation

"We are pleased to have reached a resolution with Catalyst that provides an agreeable solution to this patent dispute," said Rob Ball, CEO of Shoulder Innovations. He said protecting intellectual property remains fundamental to ensuring continued investment benefits stakeholders, including surgeons and patients.

Washington, D.C. – September 11, 2026 -- NovoTech Patent Firm Founding Director Babak Akhlaghi has secured recognition from three separate intellectual property industry rankings within a single cycle, including a listing in the IAM Strategy 300 guide.

Akhlaghi earns triple recognition across global IP rankings

Akhlaghi has been named to the IAM Strategy 300, a guide identifying individuals viewed as leaders in developing and implementing IP strategies that maximize portfolio value. He was also recognized in WIPR Leaders 2026, a ranking highlighting IP professionals worldwide, and was selected to Super Lawyers for the eighth consecutive year.

Shenzhen – September 09, 2026 -- The Cologne Regional Court has upheld an interim injunction against Shenzhen Qudong Future Technology Co., Ltd. ("AEKE") for infringing a registered EU design held by Shenzhen Speediance Life Tech Limited ("Speediance") for its Gym Monster smart strength training system, barring AEKE from advertising, offering or selling the disputed equipment in Germany.

Court confirms original injunction remains fully effective

Momence, Illinois – September 08, 2026 -- FutureCeuticals, Inc. and Aura Scientific have settled a patent and trademark dispute over Aura's cognitive-health ingredient "NeuroRush," ending the product and replacing it with a new distribution partnership for FutureCeuticals' whole coffee cherry extract, sold as "CognatiQ" and "NeuroFactor."

Settlement terminates NeuroRush, validates FutureCeuticals' IP portfolio

The resolution confirms the validity of FutureCeuticals' intellectual property in the cognitive health ingredient category, according to J. Randal Wexler, the company's Vice President and General Counsel. Aura's NeuroRush ingredient will be discontinued as part of the agreement.